Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT …
JD Cherry, EA Mortimer, JG Hackell… - Developments in …, 1991 - europepmc.org
The results of the following studies are reported: a longitudinal double blind trial comparing
Lederle-Takeda APDT vaccine with Lederle DTP vaccine in two, four and six month old …
Lederle-Takeda APDT vaccine with Lederle DTP vaccine in two, four and six month old …
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults
J Mertsola, O Van Der Meeren, Q He… - Clinical infectious …, 2010 - academic.oup.com
Background. Booster vaccination against tetanus and diphtheria at 10-year intervals is
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …
Post-marketing surveillance of Tetravalent Diphtheria-Tetanus-Acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine in South Korea, 2009 to 2015
YJ Choe, E Vidor, C Manson - Infectious Diseases and Therapy, 2022 - Springer
Abstract Introduction TETRAXIM™(Sanofi), a combined diphtheria, tetanus, acellular
pertussis, and inactivated poliovirus (DTaP-IPV) vaccine, has been licensed in South Korea …
pertussis, and inactivated poliovirus (DTaP-IPV) vaccine, has been licensed in South Korea …
Antibody levels for diphtheria, tetanus and pertussis in young adult females immunized with whole cell pertussis-diphtheria-tetanus toxoid vaccine in infancy
Y Meno, K Okada, Y Yamaguchi… - … zasshi. The Journal …, 2000 - europepmc.org
Antibody levels for diphtheria, tetanus and pertussis in 84 young adult females were
measured. They had been immunized with whole cell pertussis-diphtheria-tetanus toxoid …
measured. They had been immunized with whole cell pertussis-diphtheria-tetanus toxoid …
Effectiveness of acellular pertussis vaccine in a routine immunization program: a multicenter, case-control study in Japan
S Ohfuji, K Okada, T Nakano, H Ito, M Hara, H Kuroki… - Vaccine, 2015 - Elsevier
In 2008, the number of pertussis cases increased substantially among Japanese
adolescents, despite high coverage with acellular pertussis vaccine (DTaP). This study …
adolescents, despite high coverage with acellular pertussis vaccine (DTaP). This study …
[HTML][HTML] Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on …
KR Broder, KH Brown - MMWR. Morbidity and mortality weekly report, 2011 - stacks.cdc.gov
Despite sustained high coverage for childhood pertussis vaccination, pertussis remains
poorly controlled in the United States. A total of 16,858 pertussis cases and 12 infant deaths …
poorly controlled in the United States. A total of 16,858 pertussis cases and 12 infant deaths …
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children …
HJ Sharma, S Parekh, P Pujari, S Shewale… - Expert Review of …, 2023 - Taylor & Francis
Background This study assessed safety and immunogenicity of Serum Institute of India Pvt
Ltd (SIIPL)'s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster …
Ltd (SIIPL)'s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster …
Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the …
PL Moro, X Yue, P Lewis, P Haber, K Broder - Vaccine, 2011 - Elsevier
BACKGROUND: Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
vaccine was not licensed for use in adults aged≥ 65 years due to lack of sufficient efficacy …
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
HF Tseng, LS Sy, L Qian, SM Marcy… - Clinical infectious …, 2013 - academic.oup.com
Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …